ASX - By Stock
|
IHL |
Re:
Ann: IHL-675A Pre-IND meeting with FDA update
|
|
Hangover
|
66 |
19K |
17 |
25/03/21 |
25/03/21 |
ASX - By Stock
|
66
|
19K
|
17
|
|
ASX - By Stock
|
IHL |
Re:
Ann: IHL-675A outperforms existing treatment for arthritis
|
|
Hangover
|
178 |
43K |
7 |
23/03/21 |
23/03/21 |
ASX - By Stock
|
178
|
43K
|
7
|
|
ASX - By Stock
|
IHL |
Re:
Ann: IHL-675A outperforms existing treatment for arthritis
|
|
Hangover
|
178 |
43K |
3 |
16/03/21 |
16/03/21 |
ASX - By Stock
|
178
|
43K
|
3
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
Hangover
|
5.0K |
1.2M |
6 |
11/03/21 |
11/03/21 |
ASX - By Stock
|
5.0K
|
1.2M
|
6
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
Hangover
|
5.0K |
1.2M |
12 |
11/03/21 |
11/03/21 |
ASX - By Stock
|
5.0K
|
1.2M
|
12
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
Hangover
|
5.0K |
1.2M |
11 |
10/03/21 |
10/03/21 |
ASX - By Stock
|
5.0K
|
1.2M
|
11
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Cleansing Notice and Appendix 2A
|
|
Hangover
|
5 |
2.0K |
5 |
08/03/21 |
08/03/21 |
ASX - By Stock
|
5
|
2.0K
|
5
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
Hangover
|
5.0K |
1.2M |
7 |
08/03/21 |
08/03/21 |
ASX - By Stock
|
5.0K
|
1.2M
|
7
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
Hangover
|
5.0K |
1.2M |
13 |
05/03/21 |
05/03/21 |
ASX - By Stock
|
5.0K
|
1.2M
|
13
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
Hangover
|
5.0K |
1.2M |
17 |
01/03/21 |
01/03/21 |
ASX - By Stock
|
5.0K
|
1.2M
|
17
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
Hangover
|
5.0K |
1.2M |
13 |
28/02/21 |
28/02/21 |
ASX - By Stock
|
5.0K
|
1.2M
|
13
|
|
ASX - By Stock
|
IHL |
Re:
CSIRO gets License to develop medical cannibis
|
|
Hangover
|
2 |
944 |
4 |
25/02/21 |
25/02/21 |
ASX - By Stock
|
2
|
944
|
4
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
Hangover
|
5.0K |
1.2M |
4 |
17/02/21 |
17/02/21 |
ASX - By Stock
|
5.0K
|
1.2M
|
4
|
|
ASX - By Stock
|
IHL |
Re:
Ann: IHL appoints EAS Advisors LLC to facilitate US listing
|
|
Hangover
|
153 |
36K |
18 |
13/02/21 |
13/02/21 |
ASX - By Stock
|
153
|
36K
|
18
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
Hangover
|
5.0K |
1.2M |
15 |
19/01/21 |
19/01/21 |
ASX - By Stock
|
5.0K
|
1.2M
|
15
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
Hangover
|
5.0K |
1.2M |
8 |
12/01/21 |
12/01/21 |
ASX - By Stock
|
5.0K
|
1.2M
|
8
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
Hangover
|
5.0K |
1.2M |
7 |
16/12/20 |
16/12/20 |
ASX - By Stock
|
5.0K
|
1.2M
|
7
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
Hangover
|
5.0K |
1.2M |
11 |
12/12/20 |
12/12/20 |
ASX - By Stock
|
5.0K
|
1.2M
|
11
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
Hangover
|
5.0K |
1.2M |
17 |
08/12/20 |
08/12/20 |
ASX - By Stock
|
5.0K
|
1.2M
|
17
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
Hangover
|
5.0K |
1.2M |
3 |
02/12/20 |
02/12/20 |
ASX - By Stock
|
5.0K
|
1.2M
|
3
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
Hangover
|
5.0K |
1.2M |
1 |
27/11/20 |
27/11/20 |
ASX - By Stock
|
5.0K
|
1.2M
|
1
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
Hangover
|
5.0K |
1.2M |
1 |
27/11/20 |
27/11/20 |
ASX - By Stock
|
5.0K
|
1.2M
|
1
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
Hangover
|
5.0K |
1.2M |
1 |
27/11/20 |
27/11/20 |
ASX - By Stock
|
5.0K
|
1.2M
|
1
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Trading Halt
|
|
Hangover
|
237 |
53K |
18 |
22/11/20 |
22/11/20 |
ASX - By Stock
|
237
|
53K
|
18
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Trading Halt
|
|
Hangover
|
237 |
53K |
14 |
22/11/20 |
22/11/20 |
ASX - By Stock
|
237
|
53K
|
14
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Trading Halt
|
|
Hangover
|
237 |
53K |
10 |
21/11/20 |
21/11/20 |
ASX - By Stock
|
237
|
53K
|
10
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Trading Halt
|
|
Hangover
|
237 |
53K |
20 |
21/11/20 |
21/11/20 |
ASX - By Stock
|
237
|
53K
|
20
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Strong anti-inflammatory action from IHL-675A
|
|
Hangover
|
157 |
30K |
8 |
19/11/20 |
19/11/20 |
ASX - By Stock
|
157
|
30K
|
8
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
Hangover
|
5.0K |
1.2M |
2 |
18/11/20 |
18/11/20 |
ASX - By Stock
|
5.0K
|
1.2M
|
2
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Strong anti-inflammatory action from IHL-675A
|
|
Hangover
|
157 |
30K |
10 |
09/11/20 |
09/11/20 |
ASX - By Stock
|
157
|
30K
|
10
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Strong anti-inflammatory action from IHL-675A
|
|
Hangover
|
157 |
30K |
1 |
08/11/20 |
08/11/20 |
ASX - By Stock
|
157
|
30K
|
1
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Strong anti-inflammatory action from IHL-675A
|
|
Hangover
|
157 |
30K |
2 |
06/11/20 |
06/11/20 |
ASX - By Stock
|
157
|
30K
|
2
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Strong anti-inflammatory action from IHL-675A
|
|
Hangover
|
157 |
30K |
9 |
05/11/20 |
05/11/20 |
ASX - By Stock
|
157
|
30K
|
9
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Sep20 Quarterly Activities update and Appendix 4C
|
|
Hangover
|
173 |
36K |
4 |
27/10/20 |
27/10/20 |
ASX - By Stock
|
173
|
36K
|
4
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Sep20 Quarterly Activities update and Appendix 4C
|
|
Hangover
|
173 |
36K |
11 |
23/10/20 |
23/10/20 |
ASX - By Stock
|
173
|
36K
|
11
|
|
ASX - By Stock
|
IHL Biotech |
Re:
1 Billion Dollar MC.
|
|
Hangover
|
40 |
9.7K |
10 |
18/10/20 |
18/10/20 |
ASX - By Stock
|
40
|
9.7K
|
10
|
|
ASX - By Stock
|
IHL Biotech |
Re:
1 Billion Dollar MC.
|
|
Hangover
|
40 |
9.7K |
19 |
18/10/20 |
18/10/20 |
ASX - By Stock
|
40
|
9.7K
|
19
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Positive Results from IHL-675A (ARDS) in vitro Study
|
|
Hangover
|
320 |
72K |
5 |
08/10/20 |
08/10/20 |
ASX - By Stock
|
320
|
72K
|
5
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
Hangover
|
5.0K |
1.2M |
15 |
06/10/20 |
06/10/20 |
ASX - By Stock
|
5.0K
|
1.2M
|
15
|
|
ASX - By Stock
|
IHL |
Re:
Ann: IHL Receives Ethics Approval for Phase 2 OSA Trial
|
|
Hangover
|
46 |
8.8K |
3 |
24/09/20 |
24/09/20 |
ASX - By Stock
|
46
|
8.8K
|
3
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
Hangover
|
5.0K |
1.2M |
0 |
22/09/20 |
22/09/20 |
ASX - By Stock
|
5.0K
|
1.2M
|
0
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
Hangover
|
5.0K |
1.2M |
0 |
22/09/20 |
22/09/20 |
ASX - By Stock
|
5.0K
|
1.2M
|
0
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Positive Results from IHL-675A (ARDS) in vitro Study
|
|
Hangover
|
320 |
72K |
1 |
02/09/20 |
02/09/20 |
ASX - By Stock
|
320
|
72K
|
1
|
|
ASX - By Stock
|
IHL |
Re:
Top 20 reveals significant buyer
|
|
Hangover
|
36 |
11K |
0 |
17/08/20 |
17/08/20 |
ASX - By Stock
|
36
|
11K
|
0
|
|
ASX - By Stock
|
IHL |
Re:
Top 20 reveals significant buyer
|
|
Hangover
|
36 |
11K |
1 |
17/08/20 |
17/08/20 |
ASX - By Stock
|
36
|
11K
|
1
|
|
ASX - By Stock
|
IHL |
Re:
Top 20 reveals significant buyer
|
|
Hangover
|
36 |
11K |
0 |
17/08/20 |
17/08/20 |
ASX - By Stock
|
36
|
11K
|
0
|
|
ASX - By Stock
|
IHL |
Re:
Top 20 reveals significant buyer
|
|
Hangover
|
36 |
11K |
0 |
17/08/20 |
17/08/20 |
ASX - By Stock
|
36
|
11K
|
0
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
Hangover
|
5.0K |
1.2M |
9 |
15/06/20 |
15/06/20 |
ASX - By Stock
|
5.0K
|
1.2M
|
9
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
Hangover
|
5.0K |
1.2M |
3 |
14/06/20 |
14/06/20 |
ASX - By Stock
|
5.0K
|
1.2M
|
3
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
Hangover
|
5.0K |
1.2M |
5 |
13/06/20 |
13/06/20 |
ASX - By Stock
|
5.0K
|
1.2M
|
5
|
|